Cargando…

Analysis of information received during treatment and adherence to tamoxifen in breast cancer patients

This study examines whether women with breast cancer, who are adherent and non-adherent to tamoxifen, differ in their perceptions of information received during treatment. This cross-sectional study included women receiving tamoxifen as adjuvant treatment for breast cancer recruited from a teaching...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz, Aline, Rodrigues, Aline, Ferracini, Amanda, Stahlschmidt, Rebeca, Silva, Nice, Mazzola, Priscila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798421/ https://www.ncbi.nlm.nih.gov/pubmed/29416436 http://dx.doi.org/10.5114/wo.2017.72397

Ejemplares similares

Potential Drug Interactions and Drug Risk during Pregnancy and Breastfeeding: An Observational Study in a Women's Health Intensive Care Unit
por: Ferracini, Amanda Canato, et al.
Publicado: (2017)

Switching of Hormone Therapies in Breast Cancer Women
por: Medeiros, Luana Moreira de, et al.
Publicado: (2021)

Urinary Incontinence and Overactive Bladder Symptoms in Women with Breast Cancer Being Treated with Oral Hormone Therapy
por: Stahlschmidt, Rebeca, et al.
Publicado: (2020)

Clinical relevancy and risks of potential drug–drug interactions in intensive therapy
por: Rodrigues, Aline Teotonio, et al.
Publicado: (2015)

Ovarian cysts in women receiving tamoxifen for breast cancer
por: Mourits, M J E, et al.
Publicado: (1999)

Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer
por: Martinez-Cannon, Bertha Alejandra, et al.
Publicado: (2021)

Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors
por: Uslu, Yasemin, et al.
Publicado: (2023)

Effects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifen
por: Dias, Marcos Correa, et al.
Publicado: (2013)

Progestins and the endometrium in patients receiving tamoxifen
Publicado: (1999)

Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen
por: Jansen, Maurice P.H.M., et al.
Publicado: (2016)

Self-Medication Among Pregnant Women: Prevalence and Associated Factors
por: Pereira, Gabriela, et al.
Publicado: (2021)

Corrigendum: Self-Medication Among Pregnant Women: Prevalence and Associated Factors
por: Pereira, Gabriela, et al.
Publicado: (2021)

Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013)

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer
por: McCowan, C, et al.
Publicado: (2008)

TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer
por: Wang, Ming-Yang, et al.
Publicado: (2019)

Bone mineral content of women receiving tamoxifen for mastalgia.
por: Fentiman, I. S., et al.
Publicado: (1989)

Correction: Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013)

Combination Treatment of Tamoxifen with Risperidone in Breast Cancer
por: Yeh, Wei-Lan, et al.
Publicado: (2014)

Effects of treatment with chemotherapy and/or tamoxifen on the biomarkers of cardiac injury and oxidative stress in women with breast cancer
por: Silva, Fabricio Bragança, et al.
Publicado: (2017)

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer
por: Gjerde, Jennifer, et al.
Publicado: (2010)

SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment
por: Huang, Yu-Hsiang, et al.
Publicado: (2018)

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study
por: McCowan, C, et al.
Publicado: (2013)

Radiation recall dermatitis induced by tamoxifen during adjuvant breast cancer treatment
por: Rhee, Jiyoung, et al.
Publicado: (2014)

Which antidepressant agent can be used in patients receiving tamoxifen?
por: Maamri, A., et al.
Publicado: (2021)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Women with breast cancer taking chemotherapy: depression symptoms and treatment adherence
por: de Souza, Bianca Fresche, et al.
Publicado: (2014)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Initiation of Aspirin Therapy Modulates Angiogenic Protein Levels in Women with Breast Cancer Receiving Tamoxifen Therapy
por: Holmes, Chris E., et al.
Publicado: (2013)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022)

Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling
por: Hicks, Chindo, et al.
Publicado: (2012)

HIV pharmaceutical care in primary healthcare: Improvement in CD4 count and reduction in drug-related problems
por: Molino, C.G.R.C., et al.
Publicado: (2017)

Mullerian adenosarcoma of the uterus associated with tamoxifen treatment for breast cancer
por: Ceylan, Yasin, et al.
Publicado: (2015)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Histiocytic lymphoma of breast responds to tamoxifen.
por: Millis, R. R., et al.
Publicado: (1988)

Adjuvant tamoxifen for early breast cancer.
por: Smith, I.
Publicado: (1988)

The mechanism of tamoxifen in breast cancer prevention
por: Yu, F, et al.
Publicado: (2001)

Breast cancer chemoprevention: beyond tamoxifen
por: Fabian, Carol J
Publicado: (2001)

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study
por: Kelly, Catherine M, et al.
Publicado: (2010)

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years
por: Brentnall, Adam R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6hoc3gv3u1930lr6cg7acicaja